Abstract
The first application of gas chromatography mass spectrometry (GC–MS) metabolomics to the analysis of organic acid profiles in sera of asymptomatic human immunodeficiency virus (HIV)-infected individuals (n = 18) compared to uninfected controls (n = 21), is reported here. Several organic acids are well-established diagnostic biomarkers of mitochondrial dysfunction, making the analysis of the organic acid metabolome well suited to monitoring the progressive disruption of mitochondrial structure and function during HIV infection. Using a multifaceted analytical-bioinformatics procedure, at least 10 of these metabolites could be linked to (1) disrupted mitochondrial metabolism, (2) changes in lipid metabolism and (3) oxidative stress, all of which are aberrations caused by HIV infection. Because of the role of the mitochondria in apoptosis, higher levels of this type of cell death in infected (compared to uninfected) individuals was used to support GC–MS data. This study demonstrates that mass spectrometry metabolomics detects biomarkers of mitochondrial dysfunction which could potentially be developed into indicators of HIV infection, perhaps also to monitor disease progression and the response to antiretroviral treatment.
Similar content being viewed by others
References
Banda, N. K., Bernier, J., Kurahara, D. K., et al. (1992). Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. Journal of Experimental Medicine, 176, 1099–1106.
Barker, M., & Rayens, W. (2003). Partial least squares for discrimination. Journal of Chemometrics, 17, 166–173.
Barshop, B. A. (2004). Metabolomic approaches to mitochondrial disease: correlation of urine organic acids. Mitochondrion, 4, 521–527.
Bjorkhem, I., & Diczfalusy, U. (2002). Oxysterols: Friends, foes, or just fellow passengers? Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 734–742.
Broeckling, C. D., Reddy, I. R., Duran, A. L., Zhao, X., & Sumner, L. W. (2006). MET-IDEA: Data extraction tool for mass spectrometry-based metabolomics. Analytical Chemistry, 78, 4334–4341.
Calabrese, L. H., Proffitt, M. R., Gupta, M. K., et al. (1984). Serum beta 2-microglobulin and interferon in homosexual males: Relationship to clinical findings and serologic status to the human T lymphotropic virus (HTLV-III). AIDS Research, 1, 423–438.
Calza, L., Manfredi, R., & Chiodo, F. (2003). Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management. International Journal of Antimicrobial Agents, 22, 89–99.
Centlivre, M., Sala, M., Wain-Hobson, S., & Berkhout, B. (2007). In HIV-1 pathogenesis the die is cast during primary infection. Acquired Immuno Deficiency Syndrome, 21, 1–11.
Dunn, W. B., Broadhurst, D., Begley, P., et al. (2011). Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols, 6, 1060–1083.
Duran, M. (2005). Disorders of mitochondrial fatty acid oxidation. In N. Blau, M. Duran, & M. E. Blaskovics (Eds.), Physician’s guide to the laboratory diagnosis of metabolic diseases (Revised 2nd ed., pp. 309–334). Heidelberg: Springer-Verlag.
Gkrania-Klotsas, E., & Klotsas, A. (2007). HIV and HIV treatment: effects on fats, glucose and lipids. British Medical Bulletin, 84, 49–68.
Grunfeld, C., & Kotler, D. P. (1992). Wasting in the acquired immunodeficiency syndrome. Seminars in Liver Disease, 12, 175–187.
Grunfeld, C., Kotler, D. P., Hamadeh, R., Tierney, A., Wang, J., & Pierson, R. N. (1989). Hypertriglyceridemia in the acquired immunodeficiency syndrome. American Journal of Medicine, 86, 27–31.
Grunfeld, C., Pang, M., Doerrler, W., Shigenaga, J. K., Jensen, P., & Feingold, K. R. (1992). Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Journal of Clinical Endocrinology and Metabolism, 74, 1045–1052.
Guzmán, M., Lo Verme, J., Fu, J., Oveisi, F., Blázquez, C., & Piomelli, D. (2004). Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor α (PPAR-α). Journal of Biological Chemistry, 279, 27849–27854.
Hattingh, Z., Walsh, C., Veldman, F. J., & Bester, C. J. (2009). Metabolic profile of HIV-infected women in Mangaung, Free State. South African Journal of Clinical Nutrition, 22, 23–28.
Hewer, R., Vorster, J., Steffens, F. E., & Meyer, D. (2006). Applying biofluid 1H NMR-based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals. Journal of Pharmaceutical and Biomedical Analysis, 41, 1442–1446.
Hoffman, G. F., & Feyh, P. (2005). Organic acid analysis. In N. Blau, M. Duran, & M. E. Blaskovics (Eds), Physician’s guide to the laboratory diagnosis of metabolic diseases (Revised 2nd ed., pp. 27–44). Heidelberg: Springer-Verlag.
Hommes, M. J. T., Romijn, J. A., Godfried, M. H., et al. (1990). Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism and Clinical Nutrition, 39, 1186–1190.
Iuliano, L., Micheletta, F., Natoli, S., et al. (2003). Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. Analytical Biochemistry, 312, 217–223.
Jansen, C. A., van Baarle, D., & Miedema, F. (2006). HIV-specific CD4+ T cells and viremia: Who’s in control? Trends in Immunology, 27, 119–124.
Jellum, E., Kluge, T., Borresen, H. C., Stokke, O., & Eldjarn, L. (1970). Pyroglutamic aciduria—A new inborn error of metabolism. Scandinavian Journal of Clinical and Laboratory Investigation, 26, 327–335.
Kanekar, A. (2010). Biomarkers predicting progression of human immunodeficiency virus-related disease. Journal of Clinical Medicine and Research, 2, 55–61.
Krylov, S. N., Arriaga, E. A., Chan, N. W., Dovichi, N. J., & Palcic, M. M. (2000). Metabolic cytometry: Monitoring oligosaccharide biosynthesis in single cells by capillary electrophoresis. Analytical Biochemistry, 283, 133–135.
Ladha, J. S., Tripathy, M. K., & Mitra, D. (2005). Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis. Cell Death and Differentiation, 12, 1417–1428.
Larsson, A., Wachtmeister, L., von Wendt, L., Andersson, R., Hagenfeldt, L., & Herrin, K. M. (1985). Ophthalmological, psychometric and therapeutic investigations in two sisters with hereditary glutathione synthetase deficiency (5-oxoprolinuria). Neuropediatrics, 16, 131–136.
Macho, A., Castedo, M., Marchetti, P., et al. (1995). Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood, 86, 2481–2487.
Matias, I., Gonthier, M. P., Petrosino, S., et al. (2007). Role and regulation of acylethanolamides in energy balance: Focus on adipocytes and beta-cells. British Journal of Pharmacology, 152, 676–690.
Meyaard, L., Otto, S., Jonker, R., Mijnster, M., Keet, R., & Miedema, F. (1992). Programmed death of T cells in HIV-1 infection. Science, 257, 217–219.
Nakagawa, S., & Cuthill, I. C. (2007). Effect size, confidence interval and statistical significance: A practical guide for biologists. Biological Reviews of the Cambridge Philosophical Society, 82, 591–605.
Nordström, A., & Lewensohn, R. (2010). Metabolomics: Moving to the clinic. Journal of Neuroimmune Pharmacology, 5, 4–17.
Pendyala, G., & Fox, H. S. (2010). Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders. Genome Medicine, 2, 22.
Pfaller, M. A., & Diekema, D. J. (2007). Epidemiology of invasive candidiasis: A persistent public health problem. Clinical Microbiology Reviews, 20, 133–163.
Philippeos, C., Steffens, F. E., & Meyer, D. (2009). Comparative 1H NMR-based metabonomic analysis of HIV-1 sera. Journal of Biomolecular NMR, 44, 127–137.
Pinti, M., Nasi, M., Gibellini, L., et al. (2010). The Role of Mitochondria in HIV Infection and Its Treatment. Journal of Experimental and Clinical Medicine, 2, 145–155.
Pitt, J. J., Eggington, M., & Kahler, S. G. (2002). Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clinical Chemistry, 48, 1970–1980.
Psychogios, N., Hau, D. D., Peng, J., et al. (2011). The human serum metabolome. PLoS One, 6, e16957.
Redestig, H., Fukushima, A., Stenlund, H., et al. (2009). Compensation for systematic cross-contribution improves normalization of mass spectrometry based metabolomics data. Analytical Chemistry, 81, 7974–7980.
Reinecke, C., Koekemoer, G., van der Westhuizen, F. H., et al. (2011). Metabolomics of urinary organic acids in respiratory chain deficiencies in children. Metabolomics. doi:10.1007/s11306-011-0309-0.
Ricci, J. E., Munoz-Pinedo, C., Fitzgerald, P., et al. (2004). Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell, 117, 773–786.
Rodriguez de Fonseca, F., Navarro, M., Gomez, R., et al. (2001). An anorexic lipid mediator regulated by feeding. Nature, 414, 209–212.
Roederer, M. (2001). Spectral compensation for flow cytometry: Visualization artifacts, limitations, and caveats. Cytometry, 45, 194–205.
Roshal, M., Zhu, Y., & Planelles, V. (2001). Apoptosis in AIDS. Apoptosis, 6, 103–116.
Silva, A. R., Silva, C. G., Ruschel, C., et al. (2001). l-pyroglutamic acid inhibits energy production and lipid synthesis in cerebral cortex of young rats in vitro. Neurochemical Research, 26, 1277–1283.
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 457, 910–914.
Staal, F. J. T., Ela, S. W., Roederer, M., Anderson, M. T., Herzenberg, L. A., & Herzenberg, L. A. (1992). Glutathione deficiency and human immunodeficiency virus infection. Lancet, 339, 909–912.
Sysi-Aho, M., Katajamaa, M., Yetukuri, L., & Oresic, M. (2007). Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinformatics, 8, 93.
Touloumi, G., & Hatzakis, A. (2000). Natural history of HIV-1 infection. Clinics in Dermatology, 18, 389–399.
Trygg, J., Holmes, E., & Lundstedt, T. (2007). Chemometrics in metabonomics. Journal of Proteome Research, 6, 469–479.
Tuck, M. K., Chan, D. W., Chia, D., et al. (2009). Standard operating procedures for serum and plasma collection: Early detection research network consensus statement standard operating procedure integration working group. Journal of Proteome Research, 8, 113–117.
Tusher, V. G., Tibshirani, R., & Chu, G. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Science, 98, 5116–5121.
UNAIDS. (2002). AIDS epidemic update, Geneva, Switzerland. http://data.unaids.org/publications/IRC-pub03/epiupdate2002_en.pdf. Accessed 5 July 2011.
UNAIDS. (2009). AIDS epidemic update, Geneva, Switzerland. http://data.unaids.org/pub/report/2009/jc1700_epi_update_2009_en.pdf. Accessed 5 July 2011.
van Engeland, M., Nieland, L. J., Ramaekers, F. C., Schutte, B., & Reutelingsperger, C. P. (1998). Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry, 31, 1–9.
Verde, V., Fogliano, V., Ritieni, A., Maiani, G., Morisco, F., & Caporaso, N. (2002). Use of N,N-dimethyl-p-phenylenediamine to evaluate the oxidative status of human plasma. Free Radical Research, 36, 869–873.
Whitmore, C. D., Hindsgaul, O., Palcic, M. M., Schnaar, R. L., & Dovichi, N. J. (2007). Metabolic cytometry. Glycosphingolipid metabolism in single cells. Analytical Chemistry, 79, 5139–5142.
Wikoff, W. R., Pendyala, G., Siuzdak, G., & Fox, H. S. (2008). Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. Journal of Clinical Investigation, 118, 2661–2669.
Wohl, D. A., McComsey, G., Tebas, P., et al. (2006). Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clinical Infectious Diseases, 43, 645–653.
World Health Organization. (2005). Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance—Africa region. http://www.who.int/hiv/pub/guidelines/clinicalstaging/pdf. Accessed 1 July 2011.
World health Organization. (2006). Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach, p. 12. http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf. Accessed 1 July 2011.
Xu, F., Zou, L., & Ong, C. N. (2009). Multiorigination of chromatographic peaks in derivatized GC/MS metabolomics: A confounder that influences metabolic pathway interpretation. Journal of Proteome Research, 8, 5657–5665.
Acknowledgments
This work was supported by the following institutions and agencies: the National Research Foundation; Biotechnology Partnerships and Development (BIOPAD, now called the Technology Innovation Agency); the Medical Research Council; the Centre for the Study of AIDS and the Faculty of Science at the University of Pretoria.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Williams, A., Koekemoer, G., Lindeque, Z. et al. Qualitative serum organic acid profiles of HIV-infected individuals not on antiretroviral treatment. Metabolomics 8, 804–818 (2012). https://doi.org/10.1007/s11306-011-0376-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-011-0376-2